Enhancing effect of manganese on L-DOPA-induced apoptosis in PC12 cells: Role of oxidative stress

Journal of Neurochemistry

Volumn 73, Issue 3, 1999, Pages 1155-1163

  Migheli, Rossana ^a   Godani, Chiara ^a   Sciola, Luigi ^a   Delogu, Maria R ^a   Serra, Pier Andrea ^a   Zangani, Danilo ^a   De Natale, Guglielmo ^a   Miele, Egidio ^a   Desole, Maria S ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Apoptosis; Autoxidation; Dopamine; L DOPA; Manganese; PC12 cells

Indexed keywords

ACETYLCYSTEINE; LEVODOPA; MANGANESE;

APOPTOSIS; ARTICLE; AUTOOXIDATION; CATECHOLAMINE NERVE CELL; CELL DEATH; CELL LYSATE; CELL STRAIN; CELL VIABILITY; CYTOTOXICITY; FLOW CYTOMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; ASCORBIC ACID; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOPAMINE AGENTS; DRUG SYNERGISM; FLOW CYTOMETRY; LEVODOPA; MANGANESE POISONING; OXIDATIVE STRESS; PC12 CELLS; RATS;

EID: 0032867198     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0731155.x     Document Type: Article

References (40)

1. Alinovi R., Vettori M. V., Mutti A., Cavazzini S., Bacchini A., and Bergamaschi E. (1996) Dopamine (DA) metabolism in PC12 cells exposed to manganese (Mn) at different oxidation states. Neurotoxicology 17, 743-750.
2. Anglade P., Vyas S., Javoy-Agid F., Herrero M. T., Michel P. P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E. C., and Agid Y. (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 25-31.
3. Banati R. B., Daniel S. E., and Blunt S. B. (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord. 13, 221-227.
4. Basma A. N., Morris E. J., Nicklas W. J., and Geller M. H. (1995) L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem. 64, 825-832.
5. Desole M. S., Esposito G., Migheli R., Fresu L., Sircana S., Zangani D., Miele M., and Miele E. (1995) Cellular defence mechanisms in the striatum and of young and aged rats subchronically exposed to manganese. Neuropharmacology 34, 298-305.
6. Desole M. S., Esposito G., Migheli R., Sircana S., Delogu M. R., Fresu L., Miele M., De Natale G., and Miele E. (1997a) Glutathione deficiency potentiates manganese toxicity in rat striatum and brainstem and in PC12 cells. Pharmacol. Res. 36, 285-292.
7. Desole M. S., Sciola L., Delogu M. R., Sircana S., Migheli R., and Miele E. (1997b) Manganese and 1-methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced apoptosis in PC12 cells: role of oxidative stress. Neurochem. Int. 31, 169-176.
8. Donaldson J. (1987) The physiopathological significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8, 451-462.
9. Florence T. M. and Stauber J. L. (1989) Manganese catalysis of dopamine oxidation. Sci. Total Environ. 78, 233-240.
10. Galvani P., Fumagalli P., and Santagostino A. (1995) Vulnerability of mitochondrial complex I in PC12 cells exposed to manganese. Eur. J. Pharmacol. 293, 377-383.
11. 2+ sequestration by mitochondria and inhibition of oxidative phosphorylation. Toxicol. Appl. Pharmacol. 115, 1-5.
12. Graham D. G. (1984) Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 5, 113-118.
13. 2 by iron salts. Proc. R. Soc. Lond. [A] 147, 332-351.
14. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
15. Han S. K. and Cohen G. (1996) Inhibition of catalase in mesencephalic culture by L-DOPA and dopamine. Neurochem. Int. 29, 645-649.
16. Hartley A., Stone J. M., Heron C., Cooper J. M., and Schapira A. H. V. (1994) Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J. Neurochem. 63, 1987-1990.
17. Hastings T. G., Lewis D. A., and Zigmond M. J. (1996) Role of oxidative stress in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93, 1056-1061.
18. Hirata Y., Adachi K., and Kiuchi K. (1998) Activation of JNK pathways and induction of apoptosis by manganese in PC12 cells. J. Neurochem. 71, 1607-1615.
19. Jellinger K. (1999) The role of iron in neurodegeneration. Prospect for pharmacotherapy of Parkinson's disease. Drugs Aging 14, 115-140.
20. Klegeris A., Korkina L. G., and Greenfeld S. A. (1995) Autoxidation of dopamine: a comparison of luminescence and spectrophotometric detection in basic solutions. Free Radic. Biol. Med. 18, 215-222.
21. Lai C. T. and Yu P. H. (1997) Dopamine and L-β-3,4-dihydroxyphenylalanine hydrochloride (L-DOPA)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem. Pharmacol. 53, 363-372.
22. Liccione J. J. and Maines M. D. (1988) Selective vulnerability of glutathione metabolism and cellular defense mechanism in rat striatum to manganese. J. Pharmacol. Exp. Ther. 247, 156-161.
23. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
24. Miller D. M., Buettner G. R., and Aust S. D. (1990) Transition metals as catalysts of "autoxidation" reactions. Free Radic. Biol. Med. 18, 215-222.
25. Mochizuki H., Goto K., Mori H., and Mizuno Y. (1996) Histochemical detection of apoptosis in Parkinson's disease. J. Neural. Sci. 137, 120-123.
26. Nakao N., Nakai K., and Itakura T. (1997) Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro. Brain Res. 777, 202-209.
27. Pardo B., Mena M. A., Casajeros M. J., Paino C. L., and De Yebenes J. G. (1995) Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidant. Brain Res. 682, 133-143.
28. Parenti M., Flauto C., Parati E., Vescovi A., and Groppetti A. (1986) Manganese neurotoxicity: effects of L-DOPA and pargyline treatments. Brain Res. 367, 8-13.
29. Parsons P. G. (1985) Modification of dopa toxicity in human tumour cells. Biochem. Pharmacol. 34, 1801-1807.
30. Przedborski S., Jackson-Lewis V., and Fahn S. (1995) Antiparkinsonian therapies and brain mitochondrial complex I activity. Mov. Disord. 10, 312-317.
31. Rabinovich A. D. and Hastings T. G. (1998) Role of endogenous glutathione in the oxidation of dopamine. J. Neurochem. 71, 2071-2078.
32. Sandstrom P. A., Mannie M. D., and Buttke T. H. (1994) Inhibition of activation-induced death in T cell hybridomas by thiol antioxidant: oxidative stress as a mediator of apoptosis. J. Leukocyte Biol. 55, 221-226.
33. Seaton T. A., Cooper M. J., and Schapira A. H. V. (1997) Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res. 777, 110-118.
34. Shen X. M. and Dryhurst G. (1998) Iron-and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine: possible insights into iron-and manganese-mediated dopaminergic neurotoxicity. Chem. Res. Toxicol. 11, 824-837.
35. Spencer J. P., Jenner A., Aruoma O. I., Evans P. J., Jenner P., Lees A. J., Marsden D. C., and Halliwell B. (1994) Intense oxidative DNA damage promoted by L-DOPA and its metabolites. Implications for neurodegenerative diseases. FEBS Lett. 353, 246-250.
36. Spencer J. P., Jenner A., and Halliwell B. (1995) Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinson's disease. Neuroreport 6, 1480-1484.
37. Sun A. Y., Yang W. L., and Kim H. D. (1993) Free radical and lipid peroxidation in manganese-induced neuronal cell injury. Ann. NY Acad. Sci. 679, 358-363.
38. Walkinshaw G. and Waters C. M. (1995) Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease. J. Clin. Invest. 95, 2458-2464.
39. Ziv I., Melamed E., Nardi N., Luria D., Achiron A., Offen D., and Barzilai A. (1994) Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci. Lett. 170, 136-140.
40. Ziv I., Zilkha-Falb R., Offen D., Shirvan A., Barzilai A., and Melamed E. (1997) Levodopa induces apoptosis in cultured neuronal cells: a possible accelerator of nigrostriatal degeneration in Parkinson's disease? Mov. Disord. 12, 17-23.